XENE - Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Logo

XENE - Xenon Pharmaceuticals Inc

https://www.xenon-pharma.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada.

52W High
$46.00
52W Low
$26.74
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.17
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-11.81
EV/Revenue (<3 favorable)
339.27
P/S (TTM) (<3 favorable)
403.11
P/B (<3 favorable)
4.77
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.14%
Institutions (25–75% balanced)
111.47%
Shares Outstanding
77,106,000
Float
71,596,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
7,500,000
Gross Profit (TTM)
-245,127,008
EPS (TTM)
-3.55
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-42.42%
ROE (TTM) (>15% strong)
-0.38%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-1.00
Momentum
Bearish momentum
Value
0.6148
Previous
0.8662
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025